Hyper Terminal logo
Company earnings

THC Earnings Date & History

Tenet Healthcare Corp (NEW YORK STOCK EXCHANGE, INC.) earnings schedule, consensus estimates and reported results for the last eight quarters.

Last updated Oct 28, 2026 at 4:45 PM ET

Tenet Healthcare Corp

Health Care

Next earnings date
Thursday, October 29, 2026
Reporting session
Before Open
EPS estimate
$4.67
Revenue estimate
$5.57B

Research beyond the earnings headline

What’s happening around THC?

Congressional Trading

Review purchases and sales when available, transaction and disclosure dates kept separate

Members-only details

Previews show an example layout only, not data for THC. Coverage varies by company.

THC earnings history

Report dateQuarterEPS est.EPS actualSurpriseRevenue
Thursday, July 23, 2026Q2 2026$4.26$6.12+43.6%$5.63B
Thursday, April 30, 2026Q1 2026$4.22$4.82+14.1%$5.37B
Wednesday, February 11, 2026Q4 2025$4.09$4.70+14.8%$5.53B
Tuesday, October 28, 2025Q3 2025$3.34$3.70+10.9%$5.29B

What the market is watching in THC's next report

  • The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
  • Ticker Read combines trend, relative strength and catalysts in one research view.
  • Scanners, daily catalyst context and the members-only Weekly Watchlist are included.
Free by email

Get the week's earnings by email

One free email each week: the reports that matter, when they land, and what the market is watching.

No account required. Unsubscribe any time. Research and education only, not investment advice.

Frequently asked questions

Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.

THC earnings discussion

Anyone can read. Any free Hyper Stocks account can join in.

Create a free account to join the discussion. Reading is open to everyone, commenting is free, no subscription needed.

Loading discussion…

Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.